Eagle Pharmaceuticals (EGRX) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

EGRX is expected to report earnings to fall 1.83% to $1.07 per share on February 28

Eagle Pharmaceuticals EGRX Stock Earnings Reports

Q4'23

Est.

$1.07

Q3'23

Est.

$1.09

Q2'23

Beat

by $0.11

Q1'23

Beat

by $0.33

Q4'22

Beat

by $0.28

The last earnings report on December 29 showed earnings per share of $1.09, meeting the estimate of $1.09. With 65.72K shares outstanding, the current market capitalization sits at 62.07M.

View a ticker or compare two or three

Compare

EGRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For EGRX
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical preparations

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

50 Tice Boulevard

Phone

+1 201 326-5300

Employees

134

Web

http://www.eagleus.com